JPS5350153A - Production of 11*nnacyll carbamoyl**22cyanaziridine and pharmaceutical agent containing same with antii cancer and immune stimulating action - Google Patents

Production of 11*nnacyll carbamoyl**22cyanaziridine and pharmaceutical agent containing same with antii cancer and immune stimulating action

Info

Publication number
JPS5350153A
JPS5350153A JP11989577A JP11989577A JPS5350153A JP S5350153 A JPS5350153 A JP S5350153A JP 11989577 A JP11989577 A JP 11989577A JP 11989577 A JP11989577 A JP 11989577A JP S5350153 A JPS5350153 A JP S5350153A
Authority
JP
Japan
Prior art keywords
nnacyll
antii
carbamoyl
cancer
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11989577A
Other languages
English (en)
Inventor
Berugaa Heruberuto
Garu Rudei
Kanpe Buorufuganku
Bitsukaa Ubue
Heboruto Gotsutofuriito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762644820 external-priority patent/DE2644820A1/de
Priority claimed from DE19772727550 external-priority patent/DE2727550A1/de
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of JPS5350153A publication Critical patent/JPS5350153A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C265/00Derivatives of isocyanic acid
    • C07C265/16Derivatives of isocyanic acid having isocyanate groups acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/16Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
    • C07D203/20Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carbonic acid, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/22Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C07D203/24Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/564Three-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP11989577A 1976-10-05 1977-10-05 Production of 11*nnacyll carbamoyl**22cyanaziridine and pharmaceutical agent containing same with antii cancer and immune stimulating action Pending JPS5350153A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762644820 DE2644820A1 (de) 1976-10-05 1976-10-05 Cancerostatisch und immunstimulierend wirkende 1-(n-acyl-carbamoyl)-2-cyanaziridine sowie verfahren zur herstellung derselben
DE19772727550 DE2727550A1 (de) 1977-06-18 1977-06-18 Cancerostatisch und immunstimulierend wirkende 1-(n-acyl-carbamoyl)- 2-cyanaziridine sowie verfahren zur herstellung derselben

Publications (1)

Publication Number Publication Date
JPS5350153A true JPS5350153A (en) 1978-05-08

Family

ID=25770972

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11989577A Pending JPS5350153A (en) 1976-10-05 1977-10-05 Production of 11*nnacyll carbamoyl**22cyanaziridine and pharmaceutical agent containing same with antii cancer and immune stimulating action

Country Status (22)

Country Link
US (1) US4282212A (ja)
JP (1) JPS5350153A (ja)
AR (1) AR217085A1 (ja)
AT (1) AT356129B (ja)
AU (1) AU2931477A (ja)
CA (1) CA1092606A (ja)
CS (1) CS199711B2 (ja)
DD (1) DD131927A5 (ja)
DK (1) DK438177A (ja)
ES (1) ES462890A1 (ja)
FI (1) FI772924A (ja)
FR (1) FR2367062A1 (ja)
GB (1) GB1547513A (ja)
IE (1) IE45782B1 (ja)
IT (1) IT1087759B (ja)
NL (1) NL7710790A (ja)
NO (1) NO773377L (ja)
NZ (1) NZ185319A (ja)
OA (1) OA05778A (ja)
PL (1) PL110162B1 (ja)
PT (1) PT67108B (ja)
SE (1) SE7711093L (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005510561A (ja) * 2001-11-26 2005-04-21 ザ アリゾナ ボード オブ リージェンツ 2−シアノアジリジン−1−カルボキサミドの合成

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2833986A1 (de) * 1978-08-03 1980-02-21 Boehringer Mannheim Gmbh Immunstimulierende n-substituierte aziridin-2-carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese substanzen enthalten
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
EP1027041B1 (en) * 1997-06-27 2003-10-22 Amplimed, Inc. Novel cyanoaziridines for treating cancer
US6982263B2 (en) * 2001-06-08 2006-01-03 Boehringer Ingelheim Pharmaceuticals, Inc. Nitriles useful as reversible inhibitors of cysteine proteases
AR037097A1 (es) * 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
US7611849B2 (en) * 2003-05-27 2009-11-03 Point Care Technologies Enhanced cellular assay method for use in flow cytometry or similar instruments using optically resonant particles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3406192A (en) * 1962-09-04 1968-10-15 Monsanto Co N-(aroyl) carbamates and thio carbamates
DD110492A1 (ja) * 1974-03-21 1974-12-20

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005510561A (ja) * 2001-11-26 2005-04-21 ザ アリゾナ ボード オブ リージェンツ 2−シアノアジリジン−1−カルボキサミドの合成

Also Published As

Publication number Publication date
SE7711093L (sv) 1978-04-06
IE45782B1 (en) 1982-12-01
ES462890A1 (es) 1978-09-01
CA1092606A (en) 1980-12-30
AU2931477A (en) 1979-04-12
US4282212A (en) 1981-08-04
NL7710790A (nl) 1978-04-07
IT1087759B (it) 1985-06-04
GB1547513A (en) 1979-06-20
CS199711B2 (en) 1980-07-31
AR217085A1 (es) 1980-02-29
FR2367062A1 (fr) 1978-05-05
PT67108A (de) 1977-11-01
AT356129B (de) 1980-04-10
DK438177A (da) 1978-04-06
FR2367062B1 (ja) 1981-11-13
OA05778A (fr) 1981-05-31
PL201285A1 (pl) 1979-03-12
PL110162B1 (en) 1980-07-31
NO773377L (no) 1978-04-06
PT67108B (de) 1979-03-14
ATA706577A (de) 1979-09-15
NZ185319A (en) 1979-03-16
IE45782L (en) 1978-04-05
FI772924A (fi) 1978-04-06
DD131927A5 (de) 1978-08-09

Similar Documents

Publication Publication Date Title
IL51660A (en) Hentriakontapetides being -endorphins their preparation and pharmaceutical compostions containing them
JPS5513280A (en) Platinummdiamine complex*its manufacture* manufacture of cancer therapy drug using said complex and drug produced thereby
JPS5231063A (en) Production of novel 17 betaaester of nandrolone and novel pharmaceutical agent containing same with assimirating action
JPS52110875A (en) Production of beef like flavor substance and said flavor imparting agent
JPS52131564A (en) Production of naphthaline derivatives and use thereof
ZA761866B (en) Cosmetic emulsions of the water-in-oil type and their production
BE849788A (fr) Ethers d'imidazolyl-oximes et medicaments qui en contiennent
IL51840A0 (en) Trans-hexahydro-pyrido-indoles their production and pharmaceutical compositions containing them
IL50052A (en) Thioureas and their use as miticides
JPS52105168A (en) Production of 1*22 benzisothiazolinee33ones and use of same as pharmaceutical agent
JPS52153971A (en) Production of novel pyridine and use of same as medicine
JPS5331670A (en) Production of aminoalkylideneaminoo 1*44dihydropyridine and use of same as medicine
ZA761865B (en) Cosmetic emulsions and their production
CA928290A (en) 5'-0-ester of ara-cytidine and their preparation
JPS5350153A (en) Production of 11*nnacyll carbamoyl**22cyanaziridine and pharmaceutical agent containing same with antii cancer and immune stimulating action
ZA761867B (en) Cosmetic emulsions and their production
JPS5392784A (en) 1*44dihydropyridine derivative and vasolidator drugs containing same
GB1518764A (en) Isobutyramides their preparation and therapeutic composititions containing them
NZ185151A (en) Production of mycofungicidal products and their use
JPS5223081A (en) 1*44dihydropyridines and application to remedy
AU517665B2 (en) N-glucofuranosid-6-yl-n3-nitroso-ureas and their use in the treatment of tumours and leukaemia
JPS5273885A (en) Benzopyron derivative and its production and drugs having antiiallergy effect containing same
JPS52156869A (en) Production of benzomorphane derivatives and medical composition containing same
JPS5223010A (en) Preparation and use of 1*11 dichlorr44methyll33hydroxyy bentt11en
JPS539757A (en) Production of taunorbicine derivatives and pharmaceutical composition for treating tumor of human